首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1976957篇
  免费   145260篇
  国内免费   3790篇
耳鼻咽喉   28706篇
儿科学   66562篇
妇产科学   55592篇
基础医学   280833篇
口腔科学   53939篇
临床医学   170874篇
内科学   394428篇
皮肤病学   42490篇
神经病学   156122篇
特种医学   78700篇
外国民族医学   939篇
外科学   305477篇
综合类   43006篇
现状与发展   1篇
一般理论   594篇
预防医学   147994篇
眼科学   44580篇
药学   145175篇
  2篇
中国医学   3872篇
肿瘤学   106121篇
  2018年   20012篇
  2017年   15412篇
  2016年   16785篇
  2015年   19050篇
  2014年   26788篇
  2013年   41220篇
  2012年   56143篇
  2011年   59536篇
  2010年   35833篇
  2009年   34106篇
  2008年   56987篇
  2007年   60936篇
  2006年   61217篇
  2005年   59897篇
  2004年   58038篇
  2003年   56266篇
  2002年   55208篇
  2001年   93319篇
  2000年   96541篇
  1999年   82142篇
  1998年   22667篇
  1997年   20635篇
  1996年   20884篇
  1995年   19659篇
  1994年   18663篇
  1993年   17419篇
  1992年   64802篇
  1991年   63207篇
  1990年   61645篇
  1989年   58833篇
  1988年   54356篇
  1987年   53551篇
  1986年   50369篇
  1985年   48336篇
  1984年   36201篇
  1983年   30653篇
  1982年   18151篇
  1981年   16247篇
  1979年   32933篇
  1978年   22951篇
  1977年   19413篇
  1976年   18297篇
  1975年   19902篇
  1974年   23569篇
  1973年   22651篇
  1972年   21099篇
  1971年   19243篇
  1970年   18391篇
  1969年   16847篇
  1968年   15768篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
46.
47.
48.
Infections due to Penicillium species other than P.marneffei are rare. We identified a boy with X-linked chronic granulomatous disease (X-CGD) with a pulmonary nodule and adjacent rib osteomyelitis caused by Penicillium piceum. The only sign of infection was an elevated sedimentation rate. P. piceum was isolated by fine needle aspirate and from excised infected tissues. Surgical removal and one year of voriconazole treatment were very well tolerated and led to complete recovery. Microbiological, microscopic and molecular studies support the fungal diagnosis. P. piceum should be considered as a relevant pathogen in immunocompromised patients.  相似文献   
49.
Abstract: Background: Fetal pulse oximetry improves the assessment of fetal well‐being during labor. The objective of this study was to evaluate women's satisfaction with their experience with this additional technology. Methods: We surveyed women participating in the FOREMOST trial, a randomized controlled trial comparing the addition of fetal pulse oximetry (FPO) to conventional cardiotocograph (CTG) monitoring (intervention group), versus CTG‐only (control group), in the presence of nonreassuring fetal status during labor. Our survey evaluated 3 aspects of women's experience: labor, fetal monitoring, and participation in the research. The survey was administered within a few days of giving birth and repeated 3 months later. Results: No differences were found between the intervention and control groups for women's evaluations of their labor, fetal monitoring, research, or overall experiences when surveyed on both occasions. Within each study group, a small but statistically significant decline occurred in women's scores for their experience of labor and overall experience from the initial survey close to the time of giving birth, to 3 months later. The magnitude of differences in responses over time was similar for the both groups. Women were more satisfied after a spontaneous or assisted vaginal birth than after cesarean section. Length of time the research midwife was present had a significant positive effect on women's ratings of their experience several days after giving birth (p = 0.006), but no effect at 3 months. Conclusions: The addition of fetal pulse oximetry for the assessment of fetal well‐being during labor did not affect childbearing women's perceptions of fetal monitoring or their labor. Women evaluated their experience in the research process positively overall. Small changes occurred in women's perception of their satisfaction over time. (BIRTH 33:2 June 2006)  相似文献   
50.
PURPOSE: To determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetic characteristics of doxorubicin encapsulated in a low temperature sensitive liposome (LTSL) when given concurrently with local hyperthermia to canine solid tumors. EXPERIMENTAL DESIGN: Privately owned dogs with solid tumors (carcinomas or sarcomas) were treated. The tumors did not involve bone and were located at sites amenable to local hyperthermia. LTSL-doxorubicin was given (0.7-1.0 mg/kg i.v.) over 30 minutes during local tumor hyperthermia in a standard phase I dose escalation study. Three treatments, given 3 weeks apart, were scheduled. Toxicity was monitored for an additional month. Pharmacokinetics were evaluated during the first treatment cycle. RESULTS: Twenty-one patients were enrolled: 18 with sarcomas and 3 with carcinomas. Grade 4 neutropenia and acute death secondary to liver failure, possibly drug related, were the dose-limiting toxicities. The maximum tolerated dose was 0.93 mg/kg. Other toxicities, with the possible exception of renal damage, were consistent with those observed following free doxorubicin administration. Of the 20 dogs that received > or = 2 doses of LTSL-doxorubicin, 12 had stable disease, and 6 had a partial response to treatment. Pharmacokinetic variables were more similar to those of free doxorubicin than the marketed liposomal product. Tumor drug concentrations at a dose of 1.0 mg/kg averaged 9.12 +/- 6.17 ng/mg tissue. CONCLUSION: LTSL-doxorubicin offers a novel approach to improving drug delivery to solid tumors. It was well tolerated and resulted in favorable response profiles in these patients. Additional evaluation in human patients is warranted.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号